A cognitive therapy conceptualization of panic disorder exacerbated by interferon treatment

被引：6

作者：

Farber, GA ^{[1
]}

Levin, T

White, CA

机构：

[1] Long Isl Jewish Med Ctr, Dept Consultat & Liaison Psychiat, New Hyde Pk, NY 11040 USA

[2] Ayrshire Cent Hosp, Consulting & Clin Psychol Serv, NHS Ayrshire & Arran, Irvine KA12 8SS, Scotland

[3] Univ Glasgow, Fac Med, Glasgow G12 0XH, Lanark, Scotland

来源：

GENERAL HOSPITAL PSYCHIATRY | 2005年 / 27卷 / 05期

关键词：

panic disorder; anxiety; interferon; hepatitis C; cognitive therapy;

D O I：

10.1016/j.genhosppsych.2005.05.012

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This case conference presents a patient with von Willebrand disease, receiving year-long interferon treatment for hepatitis C. She was referred to C-L Psychiatry following a severe exacerbation of panic disorder. Our guest interviewer is Dr. Craig White, a Scottish cognitive therapist. The subsequent discussion outlines the treatment challenges of panic disorder that occurs when a patient is receiving interferon. A literature review evaluates psychological effects of interferon and biological mechanisms by which interferon may exacerbate anxiety and depression. A cognitive therapy conceptualization of interferon-induced exacerbation of panic disorder is proposed. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：329 / 337

页数：9

共 30 条

[11] A COMPARISON OF COGNITIVE THERAPY, APPLIED RELAXATION AND IMIPRAMINE IN THE TREATMENT OF PANIC DISORDER [J].

CLARK, DM ;

SALKOVSKIS, PM ;

HACKMANN, A ;

MIDDLETON, H ;

ANASTASIADES, P ;

GELDER, M .

BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :759-769

[12] Neuropsychological performance and mood states following acute interferon-β-1b administration in healthy males [J].

Exton, MS ;

Baase, J ;

Pithan, V ;

Goebel, MU ;

Limmroth, V ;

Schedlowski, M .

NEUROPSYCHOBIOLOGY, 2002, 45 (04) :199-204

[13] Emotional distress during interferon-α-2B and ribavirin treatment of chronic hepatitis C [J].

Fontana, RJ ;

Schwartz, SM ;

Gebremariam, A ;

Lok, ASF ;

Moyer, CA .

PSYCHOSOMATICS, 2002, 43 (05) :378-385

[14] Association between apolipoprotein E ε4 and neuropsychiatric symptoms during interferon α treatment for chronic hepatitis C [J].

Gochee, PA ;

Powell, EE ;

Purdie, DM ;

Pandeya, N ;

Kelemen, L ;

Shorthouse, C ;

Jonsson, JR ;

Kelly, B .

PSYCHOSOMATICS, 2004, 45 (01) :49-57

[15] A meta-analysis of treatment outcome for panic disorder [J].

Gould, RA ;

Otto, MW ;

Pollack, MH .

CLINICAL PSYCHOLOGY REVIEW, 1995, 15 (08) :819-844

[16] Interpretive bias for benign sensations in panic disorder with agoraphobia [J].

Kamieniecki, GW ;

Wade, T ;

Tsourtos, G .

JOURNAL OF ANXIETY DISORDERS, 1997, 11 (02) :141-156

[17] A COMPARISON OF ALPRAZOLAM AND BEHAVIOR-THERAPY IN TREATMENT OF PANIC DISORDER [J].

KLOSKO, JS ;

BARLOW, DH ;

TASSINARI, R ;

CERNY, JA .

JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) :77-84

[18] Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy [J].

Kraus, MR ;

Schäfer, A ;

Faller, H ;

Csef, H ;

Scheurlen, M .

JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) :708-714

[19] Paroxetine for the treatment of interferon-α-induced depression in chronic hepatitis C [J].

Kraus, MR ;

Schäfer, A ;

Faller, H ;

Csef, H ;

Scheurlen, M .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) :1091-1099

[20]

Landon Terri M, 2004, J Psychiatr Pract, V10, P211, DOI 10.1097/00131746-200407000-00002

← 1 2 3 →